Literature DB >> 17016423

Drugs, their targets and the nature and number of drug targets.

Peter Imming1, Christian Sinning, Achim Meyer.   

Abstract

What is a drug target? And how many such targets are there? Here, we consider the nature of drug targets, and by classifying known drug substances on the basis of the discussed principles we provide an estimation of the total number of current drug targets.

Mesh：

Substances：

Year:  2006        PMID： 17016423     DOI： 10.1038/nrd2132

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  195 in total

Review 1.  Biology in a gray box: targeting the emergent properties of protein complexes: 2011 Yale Chemical Biology Symposium.

Authors:  Victor Wong
Journal:  Yale J Biol Med       Date:  2011-12

2.  Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery.

Authors:  Hairi Li; Hongyan Zhou; Dong Wang; Jinsong Qiu; Yu Zhou; Xiangqiang Li; Michael G Rosenfeld; Sheng Ding; Xiang-Dong Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-06       Impact factor: 11.205

Review 3.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

4.  Simplified proteomics approach to discover protein-ligand interactions.

Authors:  Youngil Chang; Jonathan P Schlebach; Ross A VerHeul; Chiwook Park
Journal:  Protein Sci       Date:  2012-07-23       Impact factor: 6.725

5.  Linguistic approach for identification of medication names and related information in clinical narratives.

Authors:  Thierry Hamon; Natalia Grabar
Journal:  J Am Med Inform Assoc       Date:  2010 Sep-Oct       Impact factor: 4.497

6.  An automated pipeline to screen membrane protein 2D crystallization.

Authors:  Changki Kim; Martin Vink; Minghui Hu; James Love; David L Stokes; Iban Ubarretxena-Belandia
Journal:  J Struct Funct Genomics       Date:  2010-03-27

7.  Protein kinase affinity reagents based on a 5-aminoindazole scaffold.

Authors:  Ratika Krishnamurty; Amanda M Brock; Dustin J Maly
Journal:  Bioorg Med Chem Lett       Date:  2010-10-21       Impact factor: 2.823

Review 8.  Recent Progress in the Understanding of Obesity: Contributions of Genome-Wide Association Studies.

Authors:  Mette Korre Andersen; Camilla Helene Sandholt
Journal:  Curr Obes Rep       Date:  2015-12

9.  Discovery of a ZIP7 inhibitor from a Notch pathway screen.

Authors:  Erin Nolin; Sara Gans; Luis Llamas; Somnath Bandyopadhyay; Scott M Brittain; Paula Bernasconi-Elias; Kyle P Carter; Joseph J Loureiro; Jason R Thomas; Markus Schirle; Yi Yang; Ning Guo; Guglielmo Roma; Sven Schuierer; Martin Beibel; Alicia Lindeman; Frederic Sigoillot; Amy Chen; Kevin X Xie; Samuel Ho; John Reece-Hoyes; Wilhelm A Weihofen; Kayla Tyskiewicz; Dominic Hoepfner; Richard I McDonald; Nicolette Guthrie; Abhishek Dogra; Haibing Guo; Jian Shao; Jian Ding; Stephen M Canham; Geoff Boynton; Elizabeth L George; Zhao B Kang; Christophe Antczak; Jeffery A Porter; Owen Wallace; John A Tallarico; Amy E Palmer; Jeremy L Jenkins; Rishi K Jain; Simon M Bushell; Christy J Fryer
Journal:  Nat Chem Biol       Date:  2019-01-14       Impact factor: 15.040

Review 10.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.